Ulrike Eismann

486 citations

16 papers · 355 indexed · h-index 10

Impact in

Music top 2%
- Diverse Music Education Insights
Nephrology
- Dialysis and Renal Disease Management

Papers in ⓘ

Nephrology 4
- Chronic Kidney Disease and Diabetes 3
- Dialysis and Renal Disease Management 2
Biotechnology 3
- Cancer Research and Treatments 2

Co-authors: Joachim Stoeber (1 shared paper)Olaf Oberschmidt (8 shared papers)Axel-Rainer Hanauske (4 shared papers)Hartmut M. Hanauske‐Abel (3 shared papers)Günter Stein (5 shared papers)Reinhold Deppisch (4 shared papers)Heike Pospisil (2 shared papers)Doreen Ma (2 shared papers)
Journals: Journal of Clinical Oncology (3 papers)Investigational New Drugs (3 papers)Kidney International (3 papers)The Nephron journals/Nephron journals (3 papers)Blood Purification (1 paper)
Partner nations: Germany United States Taiwan

In The Last Decade

Ulrike Eismann

16 papers receiving 340 citations

Peers

Countries citing papers authored by Ulrike Eismann

Since Specialization

Citations

This map shows the geographic impact of Ulrike Eismann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Eismann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Eismann more than expected).

Fields of papers citing papers by Ulrike Eismann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Eismann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Eismann. The network helps show where Ulrike Eismann may publish in the future.

Co-authors

The 25 scholars most cited alongside Ulrike Eismann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ulrike Eismann Line = papers co-authored together Ulrike Eismann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Perfectionism in young musicians: Relations with motivation, effort, achievement, and distress Personality and Individual Differences ·Joachim Stoeber, Ulrike Eismann	2007	131
2	In vitro chemosensitivity of freshly explanted tumor cells to pemetrexed is correlated with target gene expression Investigational New Drugs ·Axel-Rainer Hanauske, Ulrike Eismann, Olaf Oberschmidt, Heike Pospisil, Steve Hoffmann, Hartmut M. Hanauske‐Abel, Doreen Ma, Victor Chen, Paolo Paoletti, Clet Niyikiza	2007	74
3	Antitumor activity of enzastaurin (LY317615.HCl) against human cancer cell lines and freshly explanted tumors investigated in vitro soft-agar cloning experiments Investigational New Drugs ·Axel-Rainer Hanauske, Olaf Oberschmidt, Hartmut M. Hanauske‐Abel, Michael Lahn, Ulrike Eismann	2007	30
4	Time Course of Cytokine mRNA Expression in Kidneys of Rats with Unilateral Ureteral Obstruction The Nephron journals/Nephron journals ·Manfred Sommer, Ulrike Eismann, Winnie Deuther‐Conrad, Thoralf Wendt, Thomas Mohorn, R Fünfstück, Günter Stein	2000	20
5	Increased Binding of Beta-2-Microglobulin to Blood Cells in Dialysis Patients Treated with High-Flux Dialyzers Compared with Low-Flux Membranes Contributed to Reduced Beta-2-Microglobulin Concentrations Blood Purification ·Mario Traut, Christoph C. Haufe, Ulrike Eismann, Reinhold Deppisch, Günter Stein, Günter Wolf	2007	20
6	Enzastaurin and pemetrexed exert synergistic antitumor activity in thyroid cancer cell lines in vitro. PubMed ·Olaf Oberschmidt, Ulrike Eismann, Laura Schulz, S. Struck, J. Blatter, Lahn Mm, Da Ma, Hanauske Ar	2005	15
7	Interleukin 4 Co-Stimulates the PDGF-BB- and bFGF-Mediated Proliferation of Mesangial Cells and Myofibroblasts The Nephron journals/Nephron journals ·Manfred Sommer, Ulrike Eismann, Jens Gerth, G Stein	2002	12
8	Expression of β2-microglobulin and c-fos mRNA: Is there an influence of high- or low-flux dialyzer membranes? Kidney International ·Christoph C. Haufe, Ulrike Eismann, Reinhold Deppisch, Günter Stein	2001	12
9	Fibronectin Splice Variants – Prognostic Markers for the Stage of Renal Interstitial Fibrosis in the Rat The Nephron journals/Nephron journals ·Ulrike Eismann, Manfred Sommer, Hartwig Kosmehl, Dorothea Appenroth, Christian Fleck, Günter Stein	2002	11
10	Pemetrexed: mRNA expression of the target genes TS, GARFT and DHFR correlates with the in vitro chemosensitivity of human solid tumors International Journal of Clinical Pharmacology and Therapeutics ·Ulrike Eismann, Olaf Oberschmidt, Markus Ehnert, J. Fleeth, F.E. Lüdtke	2005	9
11	Expression of beta2-microglobulin and c-fos mRNA: Is there an influence of high- or low-flux dialyzer membranes? Kidney International ·Christoph C. Haufe, Ulrike Eismann, Reinhold Deppisch, Günter Stein	2001	8
12	Thymidylate synthase gene expression in solid tumors predicts for response to pemetrexed in vitro Journal of Clinical Oncology ·Ulrike Eismann, Olaf Oberschmidt, M. Ehnert, J. Fleeth, F. Lüdtke, S. Struck, Laura Schulz, J. Blatter, Deqin Ma, A.H. Hanauske	2006	7
13	Correlations of mRNA expression and in vitro chemosensitivity to enzastaurin in freshly explanted human tumor cells Investigational New Drugs ·Axel-Rainer Hanauske, Ulrike Eismann, Olaf Oberschmidt, Heike Pospisil, Hartmut M. Hanauske‐Abel, J. Blatter, Doreen Ma, Victor Chen, Michael Lahn	2007	3
14	Expression of beta2-microglobulin and c-fos mRNA: Is there an influence of high- or low-flux dialyzer membranes? Kidney International ·Christoph C. Haufe, Ulrike Eismann, Reinhold Deppisch, Günter Stein	2001	1
15	Pemetrexed: Target gene expression in human solid tumors correlates with chemosensitivity patterns Journal of Clinical Oncology ·Olaf Oberschmidt, Ulrike Eismann, K. Platzek, M. Ehnert, J. Blatter, Michael Lahn, Deqin Ma, N. Clet, P Paoletti, A.-R. Hanauske	2004	1
16	In vitro chemosensitivity against enzastaurin correlates with gene expression of IL8 and GSK3-beta Journal of Clinical Oncology ·Olaf Oberschmidt, Ulrike Eismann, Michael Lahn, J. Fleeth, F. Lüdtke, S. Struck, Laura Schulz, J. Blatter, Duan Ma, Axel-Rainer Hanauske	2006	1

About Ulrike Eismann

Ulrike Eismann is a scholar working on Nephrology, Biotechnology, Music, Toxicology and Oncology, having authored 16 papers that have together received 355 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers), Chronic Kidney Disease and Diabetes (3 papers), Cancer therapeutics and mechanisms (2 papers), Bipolar Disorder and Treatment (2 papers), Cancer Research and Treatments (2 papers), Dialysis and Renal Disease Management (2 papers) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Music (54 citations), Nephrology (39 citations), Clinical Psychology (87 citations), Experimental and Cognitive Psychology (46 citations) and Oncology (81 citations). Ulrike Eismann has collaborated with scholars based in Germany, United States and Taiwan. Frequent co-authors include Joachim Stoeber, Olaf Oberschmidt, Axel-Rainer Hanauske, Hartmut M. Hanauske‐Abel, Günter Stein, Reinhold Deppisch, Heike Pospisil, Doreen Ma, Victor Chen and Manfred Sommer. Their work appears in journals such as Journal of Clinical Oncology, Investigational New Drugs, Kidney International, The Nephron journals/Nephron journals and Blood Purification.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact